Aptose Biosciences Inc.

0.8350-0.0019-0.23%Vol 115.15K1Y Perf -66.79%
Aug 11th, 2022 15:59 DELAYED
BID0.8150 ASK0.8366
Open0.8200 Previous Close0.8369
Pre-Market- After-Market0.84
 - -  0.00 0.19%
Target Price
8.50 
Analyst Rating
Strong Buy 1.00
Potential %
917.96 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
5.11 
Earnings Rating
Strong Buy
Market Cap77.06M 
Earnings Date
2nd Aug 2022
Alpha0.00 Standard Deviation0.24
Beta1.60 

Today's Price Range

0.82000.8774

52W Range

0.71183.13

5 Year PE Ratio Range

-7.40-2.10

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
-3.61%
1 Month
-1.57%
3 Months
-17.33%
6 Months
-29.83%
1 Year
-66.79%
3 Years
-69.41%
5 Years
-42.41%
10 Years
-

TickerPriceChg.Chg.%
APTO0.8350-0.0019-0.23
AAPL168.49-0.7500-0.44
GOOG119.82-0.8300-0.69
MSFT287.02-2.1400-0.74
XOM93.192.62002.89
WFC45.250.92002.08
JNJ167.14-3.5300-2.07
FB196.640.99000.51
GE78.901.76002.28
JPM120.141.75001.48
 
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.13-0.1115.38
Q01 2022-0.15-0.1220.00
Q04 2021-0.18-0.27-50.00
Q03 2021-0.17-0.1323.53
Q02 2021-0.18-0.1516.67
Q01 2021-0.17-0.18-5.88
Q04 2020-0.16-0.17-6.25
Q03 2020-0.18-0.1516.67
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.1318.75Positive
9/2022 QR-0.1417.65Positive
12/2022 FY-0.5717.39Positive
12/2023 FY-0.6014.29Positive
Next Report Date-
Estimated EPS Next Report-0.13
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume115.15K
Shares Outstanding92.28K
Shares Float90.98M
Trades Count327
Dollar Volume96.80K
Avg. Volume260.08K
Avg. Weekly Volume348.99K
Avg. Monthly Volume185.08K
Avg. Quarterly Volume246.18K

Aptose Biosciences Inc. (NASDAQ: APTO) stock closed at 0.835 per share at the end of the most recent trading day (a -0.23% change compared to the prior day closing price) with a volume of 115.15K shares and market capitalization of 77.06M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 31 people. Aptose Biosciences Inc. CEO is William G. Rice.

The one-year performance of Aptose Biosciences Inc. stock is -66.79%, while year-to-date (YTD) performance is -38.15%. APTO stock has a five-year performance of -42.41%. Its 52-week range is between 0.7118 and 3.125, which gives APTO stock a 52-week price range ratio of 5.11%

Aptose Biosciences Inc. currently has a PE ratio of -1.30, a price-to-book (PB) ratio of 1.17, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -66.83%, a ROC of -68.91% and a ROE of -71.90%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Aptose Biosciences Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.13 for the next earnings report. Aptose Biosciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Aptose Biosciences Inc. is Strong Buy (1), with a target price of $8.5, which is +917.96% compared to the current price. The earnings rating for Aptose Biosciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aptose Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aptose Biosciences Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 14.52, ATR14 : 0.06, CCI20 : 63.83, Chaikin Money Flow : -0.17, MACD : 0.00, Money Flow Index : 46.54, ROC : 7.43, RSI : 40.46, STOCH (14,3) : 60.09, STOCH RSI : 0.89, UO : 54.48, Williams %R : -39.91), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aptose Biosciences Inc. in the last 12-months were: Denis R. Burger (Buy at a value of $14 490), Denis R. Burger (Option Excercise at a value of $11 051), Erich M. Platzer (Buy at a value of $454 240), William G. Rice (Buy at a value of $69 645)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Aptose Biosciences Inc.

Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.

CEO: William G. Rice

Telephone: +1 650 718-5028

Address: 251 Consumers Road, Toronto M2J 4R3, ON, CA

Number of employees: 31

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

71%29%

Bearish Bullish

68%32%

TipRanks News for APTO

Tue, 10 May 2022 13:40 GMT Analysts Offer Insights on Healthcare Companies: Aptose Biosciences (APTO) and Applied Molecular Transport (AMTI)

- TipRanks. All rights reserved.

Thu, 24 Mar 2022 10:40 GMT Aptose Biosciences (APTO) Gets a Buy Rating from RBC Capital

- TipRanks. All rights reserved.

Wed, 23 Mar 2022 20:35 GMT Aptose Biosciences (APTO) Gets a Buy Rating from Alliance Global Partners

- TipRanks. All rights reserved.

Wed, 23 Mar 2022 12:25 GMT Analysts Top Healthcare Picks: Aptose Biosciences (APTO), Frequency Therapeutics (FREQ)

- TipRanks. All rights reserved.

News

Stocktwits